» » ยป

Patients affected with wet AMD are one step closer to real hope for vision improvement Saint John NB

Canadians living with wet age-related macular degeneration (AMD) will be pleased to know the Common Drug Review (CDR), Canada's national drug review ...

BMO Bank of Montreal
(506) 632-0202
15 Market Square
Saint John, NB
Type
Branch with ABM

Scotiabank
(506) 658-3365
39 King Street
Saint John, NB
 
RBC - Lansdowne & Wellesley Br
(506) 634-8220
111 Lansdowne Ave
Saint John, NB
Languages
English, French
Office Hours
Monday: 10:00 - 17:00
Tuesday: 10:00 - 17:00
Wednesday: 10:00 - 17:00
Thursday: 10:00 - 17:00
Friday: 10:00 - 17:00
Saturday: Closed
Sunday: Closed

BMO Bank of Montreal
(506) 632-0221
120 Mcdonald St
Saint John, NB
Type
Branch with ABM

Scotiabank
(506) 658-3200
533 Westmorland Road
Saint John, NB
 
RBC - Main Br - Saint John
(506) 632-8080
100 King St
Saint John, NB
Languages
English, French
Office Hours
Monday: 10:00 - 17:00
Tuesday: 10:00 - 17:00
Wednesday: 10:00 - 17:00
Thursday: 10:00 - 17:00
Friday: 10:00 - 17:00
Saturday: Closed
Sunday: Closed

BMO Bank of Montreal
Fairville Boulevard
Saint John, NB
Type
ABM

Scotiabank
(506) 658-3370
365 Main Street
Saint John, NB
 
Scotiabank
(506) 658-3360
35 Main Street West
Saint John, NB
 
BMO Bank of Montreal
Westmorland Road
Saint John, NB
Type
ABM

Patients affected with wet AMD are one step closer to real hope for vision improvement

Provided By:

(NC)-Canadians living with wet age-related macular degeneration (AMD) will be pleased to know the Common Drug Review (CDR), Canada's national drug review process, which is in charge of providing recommendations on which drugs should be covered under provincial drug plans, has recently announced that Lucentis should be added to the list of medications paid for by each province.

Until now, available treatments were only able to slow the progression of the disease. Lucentis is the first and only approved treatment to improve vision in some patients. Wet AMD is a progressive disease that attacks the central vision of the eye, necessary for ordinary vision-related activities such as seeing faces, reading and driving. This decision gives real hope for vision improvement for these patients for whom the diagnosis of wet AMD could previously have meant severe central vision loss and possibly even blindness in a matter of weeks to months.

Andy Livingstone noticed remarkable results after only three injections of Lucentis. Small actions he took for granted had become impossible for him. With this new treatment, he can now slice cheese, do the washing and recognize people in the streets. He even took care of his wife after she had brain surgery, something he would not have been able to do before he started the treatment. Andy has gained back his independence.

"You can't put a price on regaining your vision and your quality of life", says Andy. "Mine has improved so much thanks to this unique treatment, I can't even put it into words."

In June, Health Canada approved the medication to treat the disease and restore some vision loss. Ontario and Quebec have decided to fight against blindness by already adding Lucentis to their provincial drug plans. It is now up to other individual provinces and territories to make the final listing and coverage decisions.

If you have been diagnosed with wet AMD or you notice a sudden change in your vision such as blurring or a blank spot in your visual field, speak to your eye doctor about this new advance in the treatment of wet AMD. Early diagnosis gives you a better chance at preserving your vision.

Credit: www.newscanada.com